Detalhe da pesquisa
1.
[Acquired platelet dysfunction with severe bleeding tendency in triple-negative myelofibrosis].
Rinsho Ketsueki
; 62(9): 1406-1411, 2021.
Artigo
em Japonês
| MEDLINE | ID: mdl-34615801
2.
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard-dose azacitidine.
Cancer Rep (Hoboken)
; 7(1): e1938, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014499